BENGALURU (Reuters) – Indian drugmaker Eris Lifesciences Ltd said on Tuesday it would acquire a portfolio of dermatology brands from Glenmark Pharmaceuticals Ltd for 3.4 billion rupees ($41.63 million)
($1 = 81.6740 Indian rupees)
(Reporting by Yagnoseni Das in Bengaluru; Editing by Shailesh Kuber)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.